References
- National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/ asthgdln.htm. Published 2007 [Last accessed Sep 19, 2007]
- Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Available at: http://www.ginasthma. org. Published November 2006 [Last accessed Sep 20, 2007]
- Banov CH. The role of budesonide in adults and children with mild-to-moderate persistent asthma. J Asthma 2004;41:5–17
- Berger WE. Budesonide inhalation suspension for the treatment of asthma in infants and children. Drugs 2005;65:1973–89
- Selroos O, Edsbäcker S, Hultquist C. Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation. J Asthma 2004;41:771–90
- Busse WW, Chervinsky P, Condemi J, et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998;101:457–63
- Shapiro G, Bronsky EA, LaForce CF, et al. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatr 1998;132:976–82
- Kemp J, Wanderer AA, Ramsdell J, et al. Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma. Ann Allergy Asthma Immunol 1999;82:463–71
- Nelson HS, Bernstein IL, Fink J, et al; for the Pulmicort Turbuhaler Study Group. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a doubleblind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Chest 1998;113:1264–71
- McFadden ER, Casale TB, Edwards TB, et al. Administration of budesonide once daily by means of Turbuhaler to subjects with stable asthma. J Allergy Clin Immunol 1999;104:46–52
- Shapiro GG, Mendelson LM, Pearlman DS. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids. Ann Allergy Asthma Immunol 2001;86:633–40
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225–44
- Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659–64
- National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma – Update on Selected Topics 2002. J Allergy Clin Immunol 2002;110(Suppl 5):S141–219
- Polgar G, Weng TR. The functional development of the respiratory system-from the period of gestation to adulthood. Am Rev Respir Dis 1979;120:625–95
- Metzger WJ, Hampel FC, Sugar M. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) is effective and safe in adults previously treated with inhaled corticosteroids. J Asthma 2002;39:65–75
- Persson G, Ankerst J, Gillen M, et al. Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers. Curr Med Res Opin 2008;24(5): 1511–7
- Pulmicort Flexhaler 90 μg and 180 μg [package insert]. Wilmington, DE: AstraZeneca LP; 2006
- Pulmicort Turbuhaler 200 μg [package insert]. Wilmington, DE: AstraZeneca LP; 2006